Aspalathus Linearis (Rooibos)

1. Definition Aspalathus Linearis (Rooibos):

Aspalathus Linearis, commonly known as Rooibos, is a plant native to South Africa that is widely used in skincare and cosmetic products for its antioxidant and anti-inflammatory properties. The plant is rich in polyphenols, flavonoids, and vitamins, making it a popular ingredient in natural skincare formulations.

2. Use:

Rooibos extract is commonly used in cosmetics for its ability to soothe and calm the skin, reduce redness and inflammation, and protect against environmental stressors. It is often included in products targeting sensitive or irritated skin, as well as anti-aging formulations due to its antioxidant properties. Rooibos is also known for its hydrating and moisturizing effects on the skin, making it a versatile ingredient in a variety of skincare products.

3. Usage Aspalathus Linearis (Rooibos):

Rooibos extract can be found in a wide range of cosmetic products, including moisturizers, serums, masks, and cleansers. It is typically included in formulations at a concentration of 1-5% to provide the desired benefits for the skin. When using products containing Rooibos extract, it is important to follow the instructions provided by the manufacturer and perform a patch test before applying to the entire face to check for any potential allergic reactions.

4. References:

- Joubert E, de Beer D, Malherbe CJ, Muller N, Bonnet SL. Profiling the phytochemical composition and biological activities of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia). J Sci Food Agric. 2011;91(1):109-24.

- McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006;20(7):519-30.

- Marnewick JL, Rautenbach F, Venter I, Neethling H, Blackhurst DM, Wolmarans P, et al. Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease. J Ethnopharmacol. 2011;133(1):46-52.